Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00439049 · ClinicalTrials.gov registry record
Substance Abuse Pre-Treatment Screening Study
A clinical trial of Substance Abuse and Alcohol Dependence, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- 7,500
- Enrollment target
- 1
- Study location
NCT00439049: Recruiting study of Substance Abuse and Alcohol Dependence, sponsored by The University of Texas Health Science Center, Houston.
NCT00439049 is a study of Substance Abuse and Alcohol Dependence that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 7,500 participants, above the 5,131-participant average among 58 other Substance Abuse trials with a reported enrollment target (46% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00439049, a study of Substance Abuse and Alcohol Dependence, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- 7,500 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal of this project is to have a consolidated consent and evaluation procedure that will lead potential subjects to the most appropriate clinical trial or human laboratory study (and its consent process) for their presenting concerns or interests. A second purpose is to have a consolidated intake data base on which secondary analyses can be conducted.
Conditions Studied
Interventions
- DRUG Naltrexone
- DRUG modafinil
- DRUG d-amphetamine
- DRUG L-Dopa
Study Locations (1)
Texas
- University of Texas Medical School- Houston, Dept. of Psychiatry Mental Sciences Institute - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,500 participants |
| Start Date | 2005-10 |
| Est. Completion | 2026-06 |
What NCT00439049 shows while recruiting
NCT00439049 is an observational study that tracks outcomes without assigning an intervention. Its 7,500 participants enrollment target places it among the larger protocols in the corpus, above the 5,131-participant average among 58 other Substance Abuse trials with a reported enrollment target (46% higher).
The record links to 5 conditions, with Substance Abuse appearing as the primary indexed condition, and to 4 interventions - of which Naltrexone is the first listed.
NCT00439049 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00439049 about?
NCT00439049 is a clinical study titled "Substance Abuse Pre-Treatment Screening Study". The overarching goal of this project is to have a consolidated consent and evaluation procedure that will lead potential subjects to the most appropriate clinical trial or human laboratory study (and its consent process) for their presenting concerns or interests. A second purpose is to have a conso...
What is the current status of trial NCT00439049?
This trial is currently recruiting. The enrollment target is 7,500 participants. The study started on 2005-10. Estimated completion is 2026-06.
What conditions does trial NCT00439049 study?
This clinical trial studies the following conditions: Substance Abuse, Alcohol Dependence, Cocaine Dependence, Opiate Dependence, Cocaine Abuse.
What interventions are being tested in trial NCT00439049?
The interventions under investigation include: Naltrexone (DRUG), modafinil (DRUG), d-amphetamine (DRUG), L-Dopa (DRUG).
Who is sponsoring clinical trial NCT00439049?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00439049 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00439049's enrollment target sits among peer trials
7,500 5th of 58 higher than 54 of 58 other Substance Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Testing ALERT With GTO in Middle Schools
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
The STop UNhealthy Substance Use Now Trial
RECRUITING · NA
-
The Trans-Led Care Study
RECRUITING · NA
-
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04809740 · 7,500 participants · NA
Evaluating the Implementation and Impact of Navigator-delivered ePRO System
- NCT05199701 · 7,500 participants · NA
Prospective Case Collection Study for New Mammography Technologies
- NCT06112418 · 7,500 participants · NA
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- NCT02915198 · 7,410 participants · Phase 4
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia